FALLS CHURCH, VA – June 30, 2015 – Inova today announced that Todd Stottlemyer has been named Chief Executive Officer, Inova Center for Personalized Health (ICPH). In this role, Stottlemyer will be responsible for developing and growing all activities on the 117-acre ICPH campus (formerly the ExxonMobil site in Falls Church) which includes the Inova Dwight and Martha Schar Cancer Institute and the Inova Translational Medicine Institute (ITMI).
Stottlemyer recently served as CEO of Acentia, LCC – a provider of software, information technology and management solutions. In 2013, he was recognized by the Washington Business Journal as one of the Washington, DC, region’s 50 “Most Admired CEOs.” In 2014, he was recognized by Virginia Business magazine as one of 31 people “…making their mark on the Commonwealth’s economy.” He returns to Inova after five years when he served as an executive vice president. During his tenure at Inova, Todd co-chaired the strategic initiative to build the Inova Translational Medicine Institute (ITMI), led by John Niederhuber, MD, former Director of the National Cancer Institute.
“We are very excited to have Todd return to Inova as CEO of the new Inova Center for Personalized Health,” said J. Knox Singleton, CEO, Inova. “Todd brings a great deal of institutional knowledge and expertise to this new campus, along with strategic business and economic savvy. He is committed to the growth and development of ICPH and advancing Inova as a global leader in personalized health, genomic research and patient care.”
Mr. Stottlemyer officially joins Inova in his new role on July 6.
Media Contact: Tracy Connell, email@example.com
Inova is a global leader in developing and applying personalized health.
Connecting researchers, clinicians and empowered consumers, we integrate genomic research for patient care, prevention and wellness. Our personalized health approach enables individuals to live longer, healthier lives.